研究者業績

森山 和広

モリヤマ カズヒロ  (moriyama kazuhiro)

基本情報

所属
藤田医科大学医学部 臨床免疫制御医学講座 准教授
(兼任)大学院 保健科学科 教授

連絡先
morimorifujita-hu.ac.jp
J-GLOBAL ID
201601006975858334
researchmap会員ID
7000015352

急性血液浄化フィルターの開発を主業務としています。1994年トレミキシン(PMX)、2015年セプザイリス(持続血液濾過器)を治験、上市し、敗血症を適用疾患として一般に集中治療部や救命救急センターで使用されています。藤田医科大学では敗血症を適用としたアダカラム(顆粒球吸着カラム)の開発を行っています。


学歴

 1

論文

 48
  • Kota Shimizu, Kazuhiro Moriyama, Naohide Kuriyama, Tomoyuki Nakamura, Takahiro Kawaji, Satoshi Komatsu, Osamu Nishida
    Renal Replacement Therapy 10 10 2024年3月2日  査読有り責任著者
  • Takahiro Kawaji, Akinao Okamoto, Kazuhiro Moriyama, Seiko Hayakawa, Akihiro Tomita, Yoshitaka Hara, Naohide Kuriyama, Tomoyuki Nakamura, Osamu Nishida
    Renal Replacement Therapy 9 53 2023年10月  査読有り責任著者
  • 清水弘太, 栗山直英, 森山和広, 川合確, 竹内大智, 中村智之, 原嘉孝, 幸村英文, 西田修
    日急性血浄化会誌 14 126-130 2023年  査読有り責任著者
  • 清水 弘太, 栗山 直英, 森山 和広, 加藤 政雄, 中村 智之, 原 嘉孝, 幸村 英文, 稲熊 大城, 西田 修
    日急性血浄化会誌 13(2) 121-125 2022年12月  
  • Nakamura T, Moriyama K, Kuriyama N, Hara Y, Komatsu S, Kawaji T, Kato Y, Ishihara T, Shintani A, Nishida O
    Membranes 12(8) 2022年8月  査読有り
    Blood purification is performed to control cytokines in critically ill patients. The relationship between the clearance (CL) and the membrane area during adsorption is not clear. We hypothesized that the CL increases with the hydrophobic area when hydrophobic binding contributes to cytokine adsorption. We investigated the relationship between the hemofilter membrane area and the CL of the high mobility group box 1 protein (HMGB-1) and interleukin-6 (IL-6). We performed experimental hemofiltration in vitro using polymethyl methacrylate membranes CH-1.8W (1.8 m2) and CH-1.0N (1.0 m2), as well as polysulfone membrane NV-18X (1.8 m2). After adding 100 mg of HMGB1 or 10 μg of IL-6 into the test solution, experimental hemofiltration was conducted for 360 min in a closed-loop circulation system, and the same amount of HMGB1 and IL-6 was added after 180 min. With CH-1.8W and CH-1.0N, both HMGB-1 and IL-6 showed a rapid concentration decrease of more than 70% at 180 min and 360 min after the re-addition. At 15 min, the CL of HMGB-1 was CH-1.8W: 28.4 and CH-1.0N: 19.8, and that of IL-6 was CH-1.8W: 41.1 and CH-1.0N: 25.4. CH-1.8W and CH-1.0N removed HMGB1 and IL-6 by adsorption and CH-1.8W was superior in CL, which increased with a greater membrane area.
  • 清水 弘太, 栗山 直英, 森山 和広, 加藤 政雄, 中村 智之, 原 嘉孝, 幸村 英文, 稲熊 大城, 西田 修
    日急性血浄化会誌 13 54-58 2022年6月  査読有り
  • 西田修, 森山和広
    日医雑誌 151 37-41 2022年4月  招待有り責任著者
  • Moriyama K, Nishida O
    International Journal of Molecular Sciences 22(16) 8882-8882 2021年8月18日  査読有り筆頭著者責任著者
    Sepsis is characterized by a dysregulated immune response to infections that causes life-threatening organ dysfunction and even death. When infections occur, bacterial cell wall components (endotoxin or lipopolysaccharide), known as pathogen-associated molecular patterns, bind to pattern recognition receptors, such as toll-like receptors, to initiate an inflammatory response for pathogen elimination. However, strong activation of the immune system leads to cellular dysfunction and ultimately organ failure. Damage-associated molecular patterns (DAMPs), which are released by injured host cells, are well-recognized triggers that result in the elevation of inflammatory cytokine levels. A cytokine storm is thus amplified and sustained in this vicious cycle. Interestingly, during sepsis, neutrophils transition from powerful antimicrobial protectors into dangerous mediators of tissue injury and organ dysfunction. Thus, the concept of blood purification has evolved to include inflammatory cells and mediators. In this review, we summarize recent advances in knowledge regarding the role of lipopolysaccharides, cytokines, DAMPs, and neutrophils in the pathogenesis of sepsis. Additionally, we discuss the potential of blood purification, especially the adsorption technology, for removing immune cells and molecular mediators, thereby serving as a therapeutic strategy against sepsis. Finally, we describe the concept of our immune-modulating blood purification system.
  • 西田修, 森山和広
    日内会誌 110 942-948 2021年6月  査読有り招待有り責任著者
  • Suzuki S, Moriyama K, Hara Y, Hinoue T, Kato Y, Hasegawa D, Kuriyama N, Nakamura T, Komatsu S, Yamashita C, Komura H, Nishida O
    Tharapeautic Apheresis and Dialysis 2021年4月  査読有り責任著者
  • 栗山直英, 川治崇泰, 長谷川大祐, 加藤由布, 下村泰代, 森山和広, 西田修
    藤田学園医学会誌 44(1) 41-44 2020年12月  査読有り
  • Hasegawa D, Kuriyama N, Hara Y, Shimomura Y, Nakamura T, Shibata J, Moriyama K, Komura H, Nishida O
    Diagnostics 10(10) E826 2020年10月  査読有り
  • 山下千鶴, 森山和広, 川治崇泰, 西田修
    ICUとCCU 44(9) 2020年10月  査読有り招待有り
  • 森山和広, 山下千鶴, 西田修
    日急性血浄化会誌 11(1) 9-16 2020年7月  査読有り筆頭著者責任著者
  • Nakamura T, Kawaji T, Harada T, Kato Y, Moriyama K, Hasegawa D, Komura H, Shibata J, Yamashita C, Kuriyama N, Hara Y, Nishida O
    Therapeutic Apheresis and Dialysis. 24(5) 476-481 2020年6月  査読有り
    We aimed to evaluate whether cardiac output assessed by transpulmonary thermodilution during blood purification is affected by the difference between the blood return temperature and core temperature. We applied different blood return temperatures using a thermostat bath during blood purification in four pigs. After the blood return temperature stabilized and blood purification process stopped, the cardiac output assessed by transpulmonary thermodilution was measured. The thermostat bath was set at 35°C, 40°C, 45°C, and 50°C, with the order changed at random; four measurements were made at each temperature. Cardiac function was evaluated by echocardiography when ice-cold saline was administered in a pig. A decrease in the blood return temperature resulted in decreased cardiac output assessed by transpulmonary thermodilution, whereas an increase resulted in increased cardiac output assessed by transpulmonary thermodilution. Echocardiography revealed that the change in the blood return temperature did not affect the left ventricular ejection fraction.
  • Moriyama K, Kato Y, Hasegawa D, Kurimoto Y, Kawaji T, Nakamura T, Kuriyama N, Shimomura Y, Nishida O
    Journal of Artificial Organs 2020年5月  査読有り筆頭著者責任著者
  • Nakamura T, Moriyama K, Shimomura Y, Kato Y, Kuriyama N, Hara Y, Yamada S, Nishida O
    Tharapeautic Apheresis and Dialysis DOI: 10.1111/1744-9987.13489 2020年3月26日  査読有り
  • Hiraiwa T, Moriyama K, Matsumoto K, Shimomura Y, Kato Y, Yamashita C, Hara Y, Kawaji T, Kurimoto Y, Nakamura T, Kuriyama N, Shibata J, Komura H, Morita K, Nishida O
    Blood Purification 49(3) 1-7 2020年2月  査読有り責任著者
    INTRODUCTION: Renal replacement therapy (RRT) is widely used in the treatment of septic acute kidney injury. However, little is known about how the adsorption properties of hemofilters used in RRT affect antibiotic concentration. Because a cytokine-adsorption membrane is frequently used in RRT, it is important to determine the antibiotic adsorption capacity of this membrane. OBJECTIVE: The present study aimed to investigate the antibiotic adsorption capacity of different hemofilter membranes by in vitro experiments using 2 antibacterial agents (linezolid and doripenem). METHODS: We performed experimental hemofiltration in vitro using polyacrylonitrile (AN69ST), polymethylmethacrylate (PMMA), and polysulfone (PS) hemofilters for 1,440 min. The test solution was a 1,000-mL substitution fluid containing 30 µg/mL linezolid and 120 µg/mL doripenem. We measured drug concentrations at the inlet, outlet, and filtrate ports of the hemofilters for 1,440 min and calculated the sieving coefficient (SC) and adsorption rate (Ra) of the drugs onto the hemofilters. RESULTS: The amount of linezolid adsorbed onto AN69ST, PMMA, and PS membranes was decreased relative to that in the control group at 15 min (p < 0.05). However, no SC for linezolid was obtained thereafter. The Ra of linezolid onto AN69ST, PMMA, and PS membranes was higher than that in the control group (p < 0.05). In contrast, no significant differences were observed in the concentrations and Ra values of doripenem adsorbed onto AN69ST, PMMA, and PS membranes compared with those in the control group. CONCLUSIONS: Doripenem was not adsorbed onto PMMA, PS, and AN69ST membranes. Linezolid was adsorbed onto PMMA, PS, and AN69ST membranes, but only temporarily, and this did not affect drug bioavailability.
  • 竹本雄一, 森山和広, 山下千鶴, 原嘉孝, 西田修
    日急性血浄化会誌 10(2) 106-110 2019年12月  査読有り
  • 山下千鶴, 森山和広, 西田修
    エンドトキシン血症救命治療研会誌 23(1) 33-43 2019年12月  査読有り
  • Kurimoto Y, Shimomura Y, Moriyama K, Nakamura T, Kuriyama N, Hara Y, Komura H, Hasegawa D, Kawaji T, Nishida O
    Fujita Medical Journal. 1-5 2019年11月  査読有り
  • Takahashi N, Nakada TA, Sakai T, Kato Y, Moriyama K, Nishida O, Oda S
    Journal of Artificial Organs 1-8 2019年10月  査読有り
  • 森山和広, 加藤由布, 長谷川大祐, 栗本恭好, 川治崇泰, 下村泰代, 西田 修
    日急性血浄化会誌 10(1) 5-9 2019年7月  査読有り筆頭著者責任著者
  • Daisuke Hasegawa, Kazuki Nishida, Yoshitaka Hara, Takahiro Kawaji, Kazuhiro Moriyama, Yasuyo Shimomura, Daisuke Niimi, Hidefumi Komura, Osamu Nishida
    Journal of intensive care 7(2) 2-2 2019年  査読有り
    Background: We examined whether high lactate level in septic patients was associated with 90-day mortality based on the patients' disseminated intravascular coagulation (DIC) status. Methods: We conducted a multicenter, retrospective, observational study of patients admitted to the intensive care unit (ICU) with a suspicion of severe infection and diagnosed with sepsis. Regression analyses were performed to estimate the interaction effect between DIC status and the lactate level. Then, the association between the lactate level and 90-day mortality was assessed in the DIC and non-DIC subgroups. Results: The data of 415 patients were analyzed. We found a significant interaction between DIC status and the lactate level for predicting 90-day mortality (pinteraction = 0.04). Therefore, we performed a subgroup analysis and found that high lactate concentration was significantly associated with 90-day mortality in the DIC group (odds ratio = 2.31, p = 0.039) but not in the non-DIC group. Conclusions: In patients with DIC, a high lactate level significantly predicted 90-day mortality; no such association was found in the non-DIC group. Thus, DIC status may serve as a possible effect modifier of lactate level in predicting mortality in patients with sepsis.
  • 森山 和広, 西田 修
    ICUとCCU 43(1) 49-57 2019年1月  招待有り筆頭著者責任著者
  • 長谷川 大祐, 森山 和広, 西田 修
    ICUとCCU 42(10) 663-670 2018年10月  招待有り
  • 山下千鶴, 森山和広, 長谷川大祐, 原嘉孝, 西田修
    日外感染症会誌 . (15) 216-220 2018年10月  査読有り
  • Yamashita C, Moriyama K, Hasegawa D, Hara Y, Kuriyama N, Nakamura T, Shibata J, Komura H, Nishida O
    Recent Advances in Dialysis Therapy in Japan Karger Publishers. 196 215-222 2018年7月  査読有り
  • Yamashita C, Moriyama K, Hasegawa D, Kato Y, Sakai T, Kawaji T, Shimomura Y, Kurimoto Y, Nagata M, Nishida O
    Blood Purification 46 269-273 2018年7月  査読有り
  • Takahiro Kawaji, Toshikazu Sakai, Kazuhiro Moriyama, Yoshitaka Hara, Tomoyuki Nakamura, Naohide Kuriyama, Yasuyo Shimomura, Yu Kato, Hidefumi Komura, Chizuru Yamashita, Yasuyoshi Kurimoto, Daisuke Hasegawa, Osamu Nishida
    Therapeutic Apheresis and Dialysis 22(3) 290-294 2018年6月1日  査読有り
    We aimed to investigate the effects of blood purification and cold saline injection sites on the transpulmonary thermodilution values. We measured the cardiac output of eight pigs in every combination of cold saline injection (left jugular and femoral veins) and blood purification sites (right jugular and femoral veins), with or without blood purification. We examined the influence of the difference between the presence and absence of blood purification, vascular sites for blood purification, and sites for cold saline injection on the transpulmonary thermodilution values. Cardiac output measured during blood purification using transpulmonary thermodilution was underestimated however, there was no difference between vascular sites. Cardiac output measured via injection of cold saline into the femoral vein was higher than that obtained through injection of cold saline into the jugular vein, with or without blood purification.
  • 山下千鶴, 西田修, 原嘉孝, 栗山直英, 中村智之, 柴田純平, 幸村英文, 森山和広
    日本急性血液浄化学会雑誌 8(2) 113-117 2017年12月  査読有り最終著者
  • Toshikazu Sakai, Yoshitaka Hara, Yu Kato, Tomoyuki Nakamura, Yasuyo Shimomura, Takahiro Kawaji, Yasuyoshi Kurimoto, Mariko Nagata, Seiko Hayakawa, Hidefumi Komura, Chizuru Yamashita, Junpei Shibata, Kazuhiro Moriyama, Osamu Nishida
    Fujita Medical Journal 2(4) 73-76 2016年11月  査読有り
    <p>Objective: Previous studies have suggested that transpulmonary thermodilution (TPTD) measurements are influenced by extracorporeal circulation methods, such as blood purification. Using pigs, we investigated the effect of extracorporeal circulation on hemodynamic measurements at two sites of cold saline injection. </p><p>Methods: Six female outbred pigs were included in the study. A vascular access site was made in the left external jugular vein. Cold saline was injected in the right external jugular vein or the right femoral vein. Hemodynamic monitoring was performed using TPTD (EV1000). Cardiac output (CO), global end-diastolic volume (GEDV), and extravascular lung water (EVLW) values were compared between extracorporeal circulation and no extracorporeal circulation. All data are expressed as median values.</p><p>Results: The following data were obtained when cold saline was injected into the jugular vein (circulation on vs. circulation off): CO, 2.7 vs. 2.9 L/min (P = 0.04); GEDV, 403 vs. 438 ml (P = 0.04); and EVLW, 310 vs. 306 ml (P = 0.92). The following data were obtained when cold saline was injected into the femoral vein (circulation on vs. circulation off): CO, 2.6 vs. 2.8 L/min (P = 0.18); GEDV, 497 vs. 500 ml (P = 0.18); and EVLW, 341 vs. 345 ml (P = 0.44).</p><p>Conclusions: Extracorporeal circulation has an effect on the accuracy of measurement of TPTD injection through the jugular vein. In contrast, no effect of extracorporeal circulation was observed when the femoral vein was used.</p>
  • 早川聖子, 西田修, 中村智之, 原嘉孝, 山下千鶴, 柴田純平, 新美太祐, 河田耕太郎, 内山 壮太, 秋山正慶, 小松聖史, 前田隆求, 柳明男, 高木沙央里, 森山和広, 岡本晃直
    日本急性血液浄化学会雑誌 7(1) 72-75 2016年6月  査読有り
  • Yoshitaka Hara, Yasuyo Shimomura, Tomoyuki Nakamura, Naohide Kuriyama, Chizuru Yamashita, Yu Kato, Taku Miyasho, Toshikazu Sakai, Shingo Yamada, Kazuhiro Moriyama, Osamu Nishida
    THERAPEUTIC APHERESIS AND DIALYSIS 19(4) 308-315 2015年8月  査読有り
    Promising results have been reported with blood purification as adjuvant treatment; however, the immunological mechanisms remain unclear. We have been developing a new blood purification system for regulating excessive immune reactions in severe sepsis and septic shock using a granulocyte adsorbing column (Adacolumn [Ada]), and a cytokine-adsorbing hemofilter (AN69ST hemofilter [AN69]). Fresh porcine blood was circulated for 6 h in five experimental groups including Ada and AN69 to assess the effects of leukocyte adsorption, phagocytic activity and adhesiveness of granulocytes. In the present study, we found that Ada mainly adsorbed granulocytes and monocytes, but not lymphocytes. The phagocytic activity level of granulocytes decreased, and adhesiveness increased, but the number of CD11b-positive cells markedly decreased in the current system. Elevated cytokine levels (IL-1 beta, IL-8 and IL-10) at the outlet of Ada were significantly lower than at the outlet of AN69 due to cytokine adsorption. Further studies are needed to better understand cellular interactions.
  • 森山和広, 小野塚紀子, 綱島英人
    人工臓器 43 232-236 2014年12月  招待有り筆頭著者責任著者
  • 下村 泰代, 西田 修, 原 嘉孝, 須賀 美華, 森 志乃, 湯本 美穂, 柴田 純平, 山下 千鶴, 森山 和広, 山田 晋吾, 宮庄 拓
    日本集中治療医学会雑誌 19(Suppl.) 230-230 2012年1月  
  • 西田修, 湯本美穂, 森山和広, 加藤由布, 下村泰代, 中村智之, 栗山直英, 原嘉孝, 伊藤舞, 野田昌宏, 秋山正慶, 早川聖子, 小松聖史, 山田晋吾, 宮庄拓
    日本アフェレシス学会雑誌 31(2) 148-155 2012年  査読有り
  • 西田 修, 原 嘉孝, 下村 泰代, 須賀 美華, 森 志乃, 柴田 純平, 湯本 美穂, 中村 智之, 栗山 直英, 安岡 なつみ, 栃井 都紀子, 内山 壮太, 伊藤 舞, 河田 耕太郎, 野田 昌宏, 秋山 正慶, 森山 和広, 山下 千鶴, 山田 晋吾, 宮庄 拓
    日本急性血液浄化学会雑誌 2(Suppl.) 37-37 2011年9月  
  • Miho Yumoto, Osamu Nishida, Kazuhiro Moriyama, Yasuyo Shimomura, Tomoyuki Nakamura, Naohide Kuriyama, Yoshitaka Hara, Shingo Yamada
    THERAPEUTIC APHERESIS AND DIALYSIS 15(4) 385-393 2011年8月  査読有り
    The high mobility group box 1 protein (HMGB1) is an alarmin that plays an important role in sepsis and has been recognized as a promising target with a wide therapeutic window; however, no drugs and devices are currently in practical use. We hypothesized that hemofilters composed of porous membranes or cytokine-adsorbing membranes could remove HMGB1 from the blood. We performed experimental hemofiltration in vitro using four types of hemofilters composed of different membranes specifically designed for continuous hemofiltration. The test solution was a 1000-mL substitution fluid containing 100 mu g of HMGB1 and 35 g of bovine serum albumin. Experimental hemofiltration was conducted for 360 min in a closed loop circulation system. Among the four membranes, surface-treated polyacrylonitrile (AN69ST) showed the highest capacity to adsorb HMGB1; it adsorbed nearly 100 mu g of HMGB1 in the initial 60 min and showed a markedly high clearance rate (60.8 +/- 5.0 mL/min) at 15 min. The polymethylmethacrylate membrane had half of the adsorption capacity of the AN69ST membrane. Although the highest sieving coefficient for HMGB1 was obtained with the high cut-off polyarylethersulfone membrane, which correlated with a constant filtrate clearance rate, albumin loss was observed. However, no such removal of both HMGB1 and albumin was observed with the polysulfone membrane and tubing. We conclude that continuous hemofiltration using the AN69ST membrane is a promising approach for HMGB1-related sepsis.
  • 湯本美穂, 西田修, 森山和広, 下村泰代, 中村智之, 栗山直英, 原嘉孝, 宮庄拓, 山田晋吾
    日本急性血液浄化学会雑誌 2(1) 97-103 2011年  査読有り
  • Thomas M, Moriyama K, Ledebo I
    Contribution Nephrology 173 119-129 2011年  査読有り
  • Osamu Nishida, Tomoyuki Nakamura, Naohide Kuriyama, Yoshitaka Hara, Miho Yumoto, Yasuyo Shimomura, Kazuhiro Moriyama
    HIGH-PERFORMANCE MEMBRANE DIALYZERS 173 172-181 2011年  査読有り招待有り
    Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) is an effective, intensive modality for sepsis treatment. Here we describe the effectiveness of SHEDD-fA, which makes the best use of three principles: dialysis, filtration and adsorption, for mediator removal in the treatment of severe sepsis. SHEDD-fA was initiated after adequate fluid resuscitation and catecholamine support had been provided. A large (2.1m(2)) polymethylmethacrylate membrane dialyzer was placed in the blood circuit. Operation conditions were as follows: blood flow rate 150 ml/min, filtration rate 1,500 ml/h (post-dilution), and dialysate flow rate 300-500 ml/min over 8-12 h daily. 55 consecutive patients with severe sepsis were studied. The following results were obtained: pressure catecholamine index significantly decreased at 3 h after initiation of septic shock, PaO(2)/F(IO2) significantly increased at 1 h after initiation of septic acute respiratory distress syndrome, a significant decrease in interleukin (IL)-6 level for 3 days was observed, and IL-6 was effectively adsorbed in one pass through the filter. The average sequential organ failure assessment score of patients was 10.1 and the mortality at 28 days was 16.4% (46 survived, 9 died). Because SHEDD-fA is an intensive and high-efficiency modality, removal of useful drugs or nutrients may be observed. Despite the fact that removal of useful substances cannot be ignored, we believe that an appropriate stage or timing can be identified so that we can avoid a vicious cycle and use blood purification with effective diffusion, filtration and adsorption. We demonstrate that SHEDD-fA may be an effective, intensive modality for the treatment of patients with severe sepsis and is a possible modality for cytokine modulation therapy. Copyright (C) 2011 S. Karger AG, Basel
  • 西田 修, 中村智之, 栗山直英, 安岡なつみ, 伊藤 舞, 内山壮太, 森山和広, 湯本美穂
    ICUとCCU 34(2) 139-146 2010年  査読有り
  • 栗山直英, 西田修, 伊藤舞, 内山壮太, 河田耕太郎, 栃井都紀子, 早川聖子, 安岡なつみ, 原嘉孝, 森山和広, 中村智之, 下村泰代, 湯本美穂
    臨床麻酔 34(3) 581-587 2010年  招待有り
  • Keishi Miwa, Kazuhiro Misumi, Kaoru Shimada, Noriaki Miyoshi, Takehiro Inoue, Yoshihiro Kawabe, Kazuhiro Moriyama, Satoshi Ibara, Tsuyomu Ikenoue, Hiroshi Sakamoto
    JOURNAL OF PERINATAL MEDICINE 35(3) 232-235 2007年  査読有り
    Aims: A novel blood purification material that we previously reported as a superantigen- and cytokine-adsorbing device (SCAD) was evaluated for its ability to adsorb unbound, unconjugated bilirubin (UUBil) in vitro and in vivo. Methods: In albumin-containing buffer, UUBil was dissolved and circulated through the SCAD column. Also, bilirubin was infused into low-body weight newborn piglets and hemoperfused for 3 h over SCAD columns. Results: In albumin-containing buffer, concentration of bilirubin decreased from 34 to 0.6 mg/dL within 5 h and the SCAD fiber turned brown, indicating that bilirubin was adsorbed onto the surface of the adsorbent and was not degraded during the circulation. Using the hyperbilirubinemia swine, clearances of total bilirubin (TBil), direct bilirubin (DBil), and indirect bilirubin (IdBil) were significantly higher (P &lt; 0.01) in the SCAD group compared with the control group. The clearances of TBil, DBil, and IdBil at 3 In after the initiation of the bilirubin infusion were 0.47, 0.53, and 0.45 mL/min, respectively, at a blood flow rate of 2.5 mL/min, and this result indicates that almost 20% of bilirubins were adsorbed to the SCAD column in a single passage. Conclusion: These results provide initial evidence that SCAD treatment is effective in the removal of UUBil and can be performed safely in newborn animals.
  • Moriyama K, Soejima Y
    POLYMETHYLMETHACRYLATE A FLEXIBLE MEMBRANE FOR A TAILORED DIALYSIS 125 222-232 1999年  査読有り筆頭著者責任著者
  • Sakai Y, Shoji H, Kobayashi T, Terada R, Sugaya H, Murakami M, Moriyama K, Minaga M, Kunimoto T, Takeyama T
    Ther Plasm 12 837-842 1993年  査読有り
  • 森山 和広, 川元健, 浜口行雄, 林正好
    Sysmex J 13(1) 109-117 1990年4月  筆頭著者責任著者

主要なMISC

 80

書籍等出版物

 22

講演・口頭発表等

 89

産業財産権

 2